Biochemical markers in persons with preclinical familial Alzheimer disease  

Oleh:

Ringman, J. M. ; Younkin, S. G. ; Pratico, D.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Neurology (Official Journal of The American Academy of Neurology) vol. 71 no. 02 (Jul. 2008), page 85-92.
Topik: DEMENTIA; AMYLOID PRECURSOR PROTEIN

Ketersediaan

Perpustakaan FK Nomor Panggil: N11.K.2008.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Background: Persons at risk for familial Alzheimer disease (FAD) provide a model in which biomarkers can be studied in presymptomatic disease. Methods: Twenty-one subjects at risk for presenilin-1 (n = 17) or amyloid precursor protein (n = 4) mutations underwent evaluation with the Clinical Dementia Rating (CDR) scale. We obtained plasma from all subjects and CSF from 11. Plasma (Aß40, Aß42, F2-isoprostanes) and CSF (F2-isoprostanes, t-tau, p-tau181, Aß40, Aß42, and Aß42/Aß40 ratio) levels were compared between FAD mutation carriers (MCs) and noncarriers (NCs). Results: Plasma Aß42 levels (25.1 pM vs 15.5 pM, p = 0.031) and the ratio of Aß42/Aß40 (0.16 vs 0.11, p = 0.045) were higher in presymptomatic MCs. Among MCs, those with CDR scores of 0.5 had lower plasma Aß42 levels than those with CDR scores of 0 (14.1 pM vs 25.1, p = 0.02). The ratio of Aß42 to Aß40 was also reduced in the CSF (0.08 vs 0.15, p = 0.046) of nondemented MCs compared to NCs. Total CSF tau and p-tau181 levels were elevated in presymptomatic FAD MCs. CSF levels of F2-isoprostanes were also elevated in MCs (n = 7, 48.6 pg/mL) compared to NCs (n = 4, 21.6 pg/mL, p = 0.031). Conclusions: Our data indicate that Aß42 is elevated in plasma in familial Alzheimer disease (FAD) mutation carriers (MCs) and suggests that this level may decrease with disease progression prior to the development of overt dementia. We also demonstrated that the ratio of Aß42 to Aß40 was reduced in the CSF of nondemented MCs and that elevations of t-tau and p-tau181 are sensitive indicators of presymptomatic disease. Our finding of elevated F2-isoprostane levels in the CSF of preclinical FAD MCs suggests that oxidative stress occurs downstream to mismetabolism of amyloid precursor protein

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali